Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis

Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis

Abstract Background Systemic sclerosis (SSc) is a clinically complex and challenging disease, that leads to skin fibrosis. Its most frequent complication is interstitial lung disease (ILD), which leads to a worse prognosis. In this situation, cyclophosphamide is considered the gold standard for its...

Full description

Bibliographic Details
Main Authors: Marina Maria Vieira de Figueiredo Caldas, Kesley Pablo Morais de Azevedo, Ana Clara de França Nunes, Victor Hugo de Oliveira, Isac Davidson Santiago Fernandes Pimenta, Isabela Dantas Torres de Araújo, Francisco Alves Bezerra Neto, Ana Katherine da Silveira Gonçalves de Oliveira, Grasiela Piuvezam
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Advances in Rheumatology
Subjects:
Systemic sclerosis
Rituximab
Interstitial lung disease
Cutaneous fibrosis
Systematic review
Online Access:https://doi.org/10.1186/s42358-021-00170-y

Internet

https://doi.org/10.1186/s42358-021-00170-y

Similar Items